Cerenome, Inc. (Nasdaq: CNSY), a CNS oncology company based in Houston, released its financial results for the second quarter of 2026, ending on June 30. The Company focuses on precision diagnostics, targeted therapeutics, and artificial intelligence in the field. Cerenome provided insights into recent business developments and upcoming highlights along with this announcement.